Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00549666 · ClinicalTrials.gov registry record · Phase 1
A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects
A Phase 1 study, sponsored by Sumitomo Pharma America.
- Completed
- Registry status
- Phase 1
- Development phase
- 23
- Enrollment target
NCT00549666 is a Phase 1 study that has completed, run by Sumitomo Pharma America. The registered enrollment target is 23 participants.
The verdict
NCT00549666, a Phase 1 study, has completed, sponsored by Sumitomo Pharma America.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 23 participants
- Enrollment target
Study Summary
A Phase 1, drug, drug, interaction study between Lurasidone HCl and Ortho-tri cyclen
Interventions
- DRUG Placebo 40 mg
- DRUG Lurasidone 40 mg
- DRUG Ortho Tri-Cyclen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2007-08 |
| Est. Completion | 2007-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00549666
The ClinicalTrials.gov registry entry for NCT00549666 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sumitomo Pharma America, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo 40 mg is the first listed.
NCT00549666 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00549666 about?
NCT00549666 is a clinical study titled "A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects". A Phase 1, drug, drug, interaction study between Lurasidone HCl and Ortho-tri cyclen
What is the current status of trial NCT00549666?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2007-08. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00549666?
The interventions under investigation include: Placebo 40 mg (DRUG), Lurasidone 40 mg (DRUG), Ortho Tri-Cyclen (DRUG).
Who is sponsoring clinical trial NCT00549666?
This trial is sponsored by Sumitomo Pharma America, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.